Free Trial

Zenas BioPharma (ZBIO) Insider Trading & Ownership

Zenas BioPharma logo
$19.79 -0.61 (-3.01%)
As of 11:04 AM Eastern
This is a fair market value price provided by Massive. Learn more.

Zenas BioPharma (NASDAQ:ZBIO) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
22.00%
Number Of
Insiders Buying
(Last 12 Months)
7
Amount Of
Insider Buying
(Last 12 Months)
$25.51M
Number Of
Insiders Selling
(Last 12 Months)
0
Get ZBIO Insider Trade Alerts

Want to know when executives and insiders are buying or selling Zenas BioPharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ZBIO Insider Buying and Selling by Quarter

Zenas BioPharma Insider and Congressional Trades History

Transaction DateInsiderBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
4/29/2026Buy35,000$17.62$616,700.00  
4/28/2026Buy25,000$18.02$450,500.00  
3/31/2026
Fairmount Funds Management Llc
Director
Buy150,000$20.00$3,000,000.00  
3/31/2026
Hongbo Lu
Hongbo Lu
Director
Buy3,768$18.63$70,197.84  
2/13/2026Buy4,160$26.36$109,657.60  
2/12/2026Buy15,700$24.85$390,145.00  
2/11/2026
Hongbo Lu
Hongbo Lu
Director
Buy25,985$22.50$584,662.50  
2/2/2026Buy57,000$17.96$1,023,720.00  
1/9/2026Buy20,000$16.55$331,000.00  
1/8/2026Buy30,000$16.30$489,000.00  
1/7/2026Buy50,000$16.38$819,000.00  
10/9/2025
Jason Raleigh Nunn
Director
Buy63,158$19.00$1,200,002.00  
10/9/2025Buy11,990$20.85$249,991.50  
10/9/2025Buy105,265$19.00$2,000,035.00  
10/9/2025
Sr One Capital Management, Llc
Major Shareholder
Buy126,315$19.00$2,399,985.00  
10/7/2025
Fairmount Funds Management Llc
Director
Buy316,219$19.00$6,008,161.00  
10/7/2025
Hongbo Lu
Hongbo Lu
Director
Buy263,160$19.00$5,000,040.00  
10/7/2025Buy36,928$20.85$769,948.80  
(Data available from 1/1/2013 forward)

ZBIO Insider Trading Activity - Frequently Asked Questions

The list of insiders at Zenas BioPharma includes Fairmount Funds Management Llc, Hongbo Lu, Jason Raleigh Nunn, Leon O Moulder Jr, Patricia L Allen, Patrick G Enright, and Sr One Capital Management, Llc. Learn more on insiders at ZBIO.

22.00% of Zenas BioPharma stock is owned by insiders. Learn more on ZBIO's insider holdings.

The following insiders have purchased ZBIO shares in the last 24 months: Fairmount Funds Management Llc ($9,008,161.00), Hongbo Lu ($6,654,891.34), Jason Raleigh Nunn ($1,200,002.00), Leon O Moulder Jr ($4,499,868.80), Patricia L Allen ($499,802.60), Patrick G Enright ($2,250,026.50), and Sr One Capital Management, Llc ($2,399,985.00).

Insiders have purchased a total of 1,398,471 ZBIO shares in the last 24 months for a total of $26,512,737.24 bought.



This page (NASDAQ:ZBIO) was last updated on 5/12/2026 by MarketBeat.com Staff.
From Our Partners